No Data
No Data
No Data
Express News | NRx Pharmaceuticals Reports Prelim. Results; Sees FY24 EPS $(0.40)
NRX Pharmaceuticals Sees FY23 Loss/Shr $0.40 >NRXP
NRX Pharmaceuticals Sees FY23 Loss/Shr $0.40 >NRXP
NRX Pharmaceuticals: Shares Will Begin Trading on Split-Adjusted Basis on April 2 >NRXP
NRX Pharmaceuticals: Shares Will Begin Trading on Split-Adjusted Basis on April 2 >NRXP
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announces its...
NRx Pharmaceuticals Announces Reverse Stock Split To Maintain Nasdaq Listing >NRXP
NRx Pharmaceuticals Announces Reverse Stock Split To Maintain Nasdaq Listing >NRXP
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. • Shimmick (NASDAQ:SHIM) is estimated
No Data